Figure 1.
Probability of occurrence of severe adverse events (grade ¾) and/or death in women initiating a nevirapine-based antiretroviral therapy in the MTCT-Plus program in Abidjan, Côte d'Ivoire
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.